Analytical Data
-
基因名
RC0497
- Application
-
别名
RC0497；
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q92IC3
-
表达区间
1-267aa
-
氨基酸序列
MSKSKAIENNGISNTNSPNGKYMAPRPEGVKPTCVVITYSVSKDIKAVREVLDERGASVHYIIDKDGTQKEYHNDLTDQAFYAGKSSWKGEVGVNKFGIGVMLINDAKSDFPAEQIGKLKEFLKDVTERYPNLDLKHDLVGLGEVTVNREGNAHIAPGSKFPWKELAEAGFGRYFETTQEQKSKLLLSLDSTGEKVNTLQENLKEYGYGVESTSTFDQFTQQAVRVFNDRYGTGLPNEEPPVSWTEAGQDVLSQLLGQTVLEQTENA
-
分子量
45.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RC0497 is a recombinant protein that has garnered significant attention in the field of biomedical research due to its potential therapeutic applications. This protein is derived from a specific strain of bacteria and is engineered to exhibit properties that can modulate immune responses. The growing prevalence of various autoimmune diseases and infections has prompted researchers to explore innovative treatments that can enhance immune system functionality without triggering adverse effects. Initial studies on RC0497 have demonstrated its ability to stimulate immune cell activation, thereby improving the body’s defensive mechanisms against pathogens. Additionally, the protein's unique structural features allow for better stability and activity compared to naturally occurring counterparts, making it a promising candidate for further development. As the understanding of immune modulation expands, RC0497’s role could extend to areas such as vaccine development and personalized medicine. Ongoing research aims to elucidate the underlying mechanisms of action, optimal dosing regimens, and potential side effects associated with its use. By exploring the versatility of RC0497, scientists hope to pave the way for novel therapeutic strategies that can revolutionize treatment protocols for a range of immunological disorders.
